Kosten der Colitis ulcerosa: eine Kalkulation aus der Perspektive der Gesetzlichen Krankenversicherung

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • A. Prenzler
  • B. Bokemeyer
  • T. Mittendorf
  • J. M.Graf Von Der Schulenburg

Organisationseinheiten

Externe Organisationen

  • Gastroenterologische Gemeinschaftspraxis Minden
Forschungs-netzwerk anzeigen

Details

Titel in ÜbersetzungCosts of ulcerative colitis within the German Statutory Health Insurance
OriginalspracheMehrere Sprachen
Seiten (von - bis)281-286
Seitenumfang6
FachzeitschriftDeutsche Medizinische Wochenschrift
Jahrgang135
Ausgabenummer7
Frühes Online-Datum9 Feb. 2010
PublikationsstatusVeröffentlicht - Feb. 2010

Abstract

Background and objectives: Studies estimating the costs of ulcerative colitis (UC) within the German setting are limited. The aim of this cross-sectional study was to collect data on the overall costs arising from the care of patients with UC and to quantify this expenditure as incurred by the German Statutory Health Insurance (SHI). Methods: Between March 2006 and July 2007 patients from 24 ambulatory gastroenterologist practices and two hospitals were enrolled in an internet-based database. Outpatient and inpatient visits, all procedures as well as drug usage were obtained from the collected data and evaluated from the perspective of the SHI, taking also into account statutory discounts and patients co-payments. The year 2007 was selected as the pricing period. Results: Data from 519 patients with UC were collected (gender ratio 1:1; average age 46 years). The average annual cost per UC patient to the SHI is 2,477.72 Euro, 74% of this amount results from drug usage, 10% from inpatient care and another 10% from ambulatory procedures. Costs increase with the severity of the disease. Conclusion: This is the first study to calculate the costs caused by UC and payed by the SHI in Germany. Future research should focus on collecting longitudinal data and also on comparing the resources used in the care of patients with other inflammatory bowel diseases, such as Crohns disease.

Schlagwörter

    Cost analyses, Germany, Inflammatory bowel disease, Ulcerative colitis

ASJC Scopus Sachgebiete

Zitieren

Kosten der Colitis ulcerosa: eine Kalkulation aus der Perspektive der Gesetzlichen Krankenversicherung. / Prenzler, A.; Bokemeyer, B.; Mittendorf, T. et al.
in: Deutsche Medizinische Wochenschrift, Jahrgang 135, Nr. 7, 02.2010, S. 281-286.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Prenzler A, Bokemeyer B, Mittendorf T, Schulenburg JMGVD. Kosten der Colitis ulcerosa: eine Kalkulation aus der Perspektive der Gesetzlichen Krankenversicherung. Deutsche Medizinische Wochenschrift. 2010 Feb;135(7):281-286. Epub 2010 Feb 9. doi: 10.1055/s-0029-1244848
Prenzler, A. ; Bokemeyer, B. ; Mittendorf, T. et al. / Kosten der Colitis ulcerosa : eine Kalkulation aus der Perspektive der Gesetzlichen Krankenversicherung. in: Deutsche Medizinische Wochenschrift. 2010 ; Jahrgang 135, Nr. 7. S. 281-286.
Download
@article{8d4480a3121741ccad461dd33a37dd34,
title = "Kosten der Colitis ulcerosa: eine Kalkulation aus der Perspektive der Gesetzlichen Krankenversicherung",
abstract = "Background and objectives: Studies estimating the costs of ulcerative colitis (UC) within the German setting are limited. The aim of this cross-sectional study was to collect data on the overall costs arising from the care of patients with UC and to quantify this expenditure as incurred by the German Statutory Health Insurance (SHI). Methods: Between March 2006 and July 2007 patients from 24 ambulatory gastroenterologist practices and two hospitals were enrolled in an internet-based database. Outpatient and inpatient visits, all procedures as well as drug usage were obtained from the collected data and evaluated from the perspective of the SHI, taking also into account statutory discounts and patients co-payments. The year 2007 was selected as the pricing period. Results: Data from 519 patients with UC were collected (gender ratio 1:1; average age 46 years). The average annual cost per UC patient to the SHI is 2,477.72 Euro, 74% of this amount results from drug usage, 10% from inpatient care and another 10% from ambulatory procedures. Costs increase with the severity of the disease. Conclusion: This is the first study to calculate the costs caused by UC and payed by the SHI in Germany. Future research should focus on collecting longitudinal data and also on comparing the resources used in the care of patients with other inflammatory bowel diseases, such as Crohns disease.",
keywords = "Cost analyses, Germany, Inflammatory bowel disease, Ulcerative colitis",
author = "A. Prenzler and B. Bokemeyer and T. Mittendorf and Schulenburg, {J. M.Graf Von Der}",
year = "2010",
month = feb,
doi = "10.1055/s-0029-1244848",
language = "Multiple languages",
volume = "135",
pages = "281--286",
journal = "Deutsche Medizinische Wochenschrift",
issn = "0012-0472",
publisher = "Georg Thieme Verlag",
number = "7",

}

Download

TY - JOUR

T1 - Kosten der Colitis ulcerosa

T2 - eine Kalkulation aus der Perspektive der Gesetzlichen Krankenversicherung

AU - Prenzler, A.

AU - Bokemeyer, B.

AU - Mittendorf, T.

AU - Schulenburg, J. M.Graf Von Der

PY - 2010/2

Y1 - 2010/2

N2 - Background and objectives: Studies estimating the costs of ulcerative colitis (UC) within the German setting are limited. The aim of this cross-sectional study was to collect data on the overall costs arising from the care of patients with UC and to quantify this expenditure as incurred by the German Statutory Health Insurance (SHI). Methods: Between March 2006 and July 2007 patients from 24 ambulatory gastroenterologist practices and two hospitals were enrolled in an internet-based database. Outpatient and inpatient visits, all procedures as well as drug usage were obtained from the collected data and evaluated from the perspective of the SHI, taking also into account statutory discounts and patients co-payments. The year 2007 was selected as the pricing period. Results: Data from 519 patients with UC were collected (gender ratio 1:1; average age 46 years). The average annual cost per UC patient to the SHI is 2,477.72 Euro, 74% of this amount results from drug usage, 10% from inpatient care and another 10% from ambulatory procedures. Costs increase with the severity of the disease. Conclusion: This is the first study to calculate the costs caused by UC and payed by the SHI in Germany. Future research should focus on collecting longitudinal data and also on comparing the resources used in the care of patients with other inflammatory bowel diseases, such as Crohns disease.

AB - Background and objectives: Studies estimating the costs of ulcerative colitis (UC) within the German setting are limited. The aim of this cross-sectional study was to collect data on the overall costs arising from the care of patients with UC and to quantify this expenditure as incurred by the German Statutory Health Insurance (SHI). Methods: Between March 2006 and July 2007 patients from 24 ambulatory gastroenterologist practices and two hospitals were enrolled in an internet-based database. Outpatient and inpatient visits, all procedures as well as drug usage were obtained from the collected data and evaluated from the perspective of the SHI, taking also into account statutory discounts and patients co-payments. The year 2007 was selected as the pricing period. Results: Data from 519 patients with UC were collected (gender ratio 1:1; average age 46 years). The average annual cost per UC patient to the SHI is 2,477.72 Euro, 74% of this amount results from drug usage, 10% from inpatient care and another 10% from ambulatory procedures. Costs increase with the severity of the disease. Conclusion: This is the first study to calculate the costs caused by UC and payed by the SHI in Germany. Future research should focus on collecting longitudinal data and also on comparing the resources used in the care of patients with other inflammatory bowel diseases, such as Crohns disease.

KW - Cost analyses

KW - Germany

KW - Inflammatory bowel disease

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=77049092313&partnerID=8YFLogxK

U2 - 10.1055/s-0029-1244848

DO - 10.1055/s-0029-1244848

M3 - Article

C2 - 20146156

AN - SCOPUS:77049092313

VL - 135

SP - 281

EP - 286

JO - Deutsche Medizinische Wochenschrift

JF - Deutsche Medizinische Wochenschrift

SN - 0012-0472

IS - 7

ER -